Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
Authors:
- 29 November 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 120 (23) , 4635-4644
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma and an aggressive malignancy. Galectin-3 (gal-3), the only antiapoptotic member of the galectin family, is overexpressed in DLBCL. While gal-3 can localize to intracellular sites, gal-3 is secreted by DLBCL cells and binds back to the cell surface in a carbohydrate-dependent manner. The major counterreceptor for gal-3 on DLBCL cells was identified as the transmembrane tyrosine phosphatase CD45. Removal of cell-surface gal-3 from CD45 with the polyvalent glycan inhibitor GCS-100 rendered DLBCL cells susceptible to chemotherapeutic agents. Binding of gal-3 to CD45 modulated tyrosine phosphatase activity; removal of endogenous cell-surface gal-3 from CD45 with GCS-100 increased phosphatase activity, while addition of exogenous gal-3 reduced phosphatase activity. Moreover, the increased susceptibility of DLBCL cells to chemotherapeutic agents after removal of gal-3 by GCS-100 required CD45 phosphatase activity. Gal-3 binding to a subset of highly glycosylated CD45 glycoforms was regulated by the C2GnT-1 glycosyltransferase, indicating that specific glycosylation of CD45 is important for regulation of gal-3–mediated signaling. These data identify a novel role for cell-surface gal-3 and CD45 in DLBCL survival and suggest novel therapeutic targets to sensitize DLBCL cells to death.Keywords
This publication has 52 references indexed in Scilit:
- Ligand Induced Galectin-3 Protein Self-associationJournal of Biological Chemistry, 2012
- Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survivalProceedings of the National Academy of Sciences, 2011
- Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cellsCell Death & Differentiation, 2011
- Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entryProceedings of the National Academy of Sciences, 2011
- Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatmentCell Death & Disease, 2010
- N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell DeathJournal of Biological Chemistry, 2010
- Galectin-1 Co-clusters CD43/CD45 on Dendritic Cells and Induces Cell Activation and Migration through Syk and Protein Kinase C SignalingJournal of Biological Chemistry, 2009
- Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphomaLeukemia, 2007
- The role of galectin-3 in cancer drug resistanceDrug Resistance Updates, 2007
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000